Emergence of carbapenemases in Pseudomonas aeruginosa: a worldwide problem

References

• Edelstein MV, Skleenova EN, Shevchenko OV et al. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. Lancet Infect. Dis. 13(10), 867–876 (2013).
   PubMed Web of Science ®Google Scholar
• Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34, 634–640 (2002).
   PubMed Web of Science ®Google Scholar
• Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect. Dis. 11, 381–393 (2011).
   PubMed Web of Science ®Google Scholar
• Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18, 306–325 (2005).
   PubMed Web of Science ®Google Scholar
• Senda K, Arakawa Y, Nakashima K et al. Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob. Agents Chemother. 40, 349–353 (1996).
   PubMed Web of Science ®Google Scholar
• Curran B, Jonas D, Grundmann H et al. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42, 5644–5649 (2004).
   PubMed Web of Science ®Google Scholar
• Cholley P, Thouverez M, Hocquet D et al. Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types. J. Clin. Microbiol. 49, 2578–2583 (2011).
   PubMed Web of Science ®Google Scholar
• García-Castillo M, Del Campo R, Morosini MI et al. Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J. Clin. Microbiol. 49, 2905–2910 (2011).
   PubMedGoogle Scholar
• Gomila M, Gallegos MC, Fernández-Baca V et al. Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain. BMC Microbiol. 13, 138 (2013).
   PubMedGoogle Scholar
• Maatallah M, Cheriaa J, Backhrouf A et al. Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. PLoS ONE 6, e25617 (2011).
   PubMedGoogle Scholar
• Seok Y, Bae IK, Jeong SH et al. Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea. J. Antimicrob. Chemother. 66, 2791–2796 (2011).
   PubMed Web of Science ®Google Scholar
• Fournier D, Richardot C, Müller E et al. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 68, 1772–1780 (2013).
   PubMedGoogle Scholar
• Mataseje LF, Bryce E, Roscoe D et al. Carbapenem-resistant Gram-negative bacilli in Canada 2009–10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J. Antimicrob. Chemother. 67, 1359–1367 (2012).
   PubMed Web of Science ®Google Scholar
• Rieber H, Frontzek A, von Baum H, Pfeifer Y. Emergence of metallo-β-lactamases GIM-1 and VIM in multidrug-resistant Pseudomonas aeruginosa in North Rhine–Westphalia, Germany J. Antimicrob. Chemother. 67, 1043–1045 (2012).
   PubMedGoogle Scholar
• Riera E, Cabot G, Mulet X et al. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem J. Antimicrob. Chemother. 66, 2022–2027 (2011).
   PubMed Web of Science ®Google Scholar
• Kiera Jacobson R, Minenza N, Nicol M, Bamford C. VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa causing an outbreak in South Africa J. Antimicrob. Chemother. 67, 1797–1798 (2012).
   PubMedGoogle Scholar
• Kitao T, Tada T, Tanaka M et al. Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC(6')-Iae in Japan. Int. J. Antimicrob. Agents 39, 518–521 (2012).
   PubMed Web of Science ®Google Scholar
• Sekiguchi J, Asagi T, Miyoshi-Akiyama T et al. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J. Clin. Microbiol. 45, 979–989 (2007).
   PubMed Web of Science ®Google Scholar
• Viedma E, Juan C, Villa J et al. VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain. Emerg. Infect. Dis. 18, 1235–1241 (2012).
   PubMedGoogle Scholar
• Walsh TR. Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents 36, S8–S14 (2010).
   PubMed Web of Science ®Google Scholar